Product Description: JIB-04 is a pan-selective Jumonji histone demethylase inihibitor with IC50s of 230, 340, 855, 445, 435, 1100, and 290 nM for JARID1A, JMJD2E, JMJD3, JMJD2A, JMJD2B, JMJD2C, and JMJD2D, respectively.
Applications: Cancer-programmed cell death
Formula: C17H13ClN4
References: [1]Wang L, et al. A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth. Nat Commun, 2013. 4: p. 2035./[2]Banelli B, et al. Small molecules targeting histone demethylase genes (KDMs) inhibit growth of temozolomide-resistant glioblastoma cells. Oncotarget. 2017 Apr 4.
CAS Number: 199596-05-9
Molecular Weight: 308.76492
Compound Purity: 98.29
Research Area: Cancer
Solubility: DMSO : 50 mg/mL (ultrasonic)/Ethanol : 2 mg/mL (ultrasonic)
Target: Apoptosis;Histone Demethylase